PPARG and metabolic dysfunction-associated steatotic liver disease: Observing that PPARγ downregulation leads to the promotion of liver fibrosis in NAFLD [18], we could potentially tie in the additional increase in smaller fat droplets seen in the liver (Figure 8C,F), specifically the increase in the fraction of smaller cells visible, with an increase in miR-27-5p.